RK
Rakesh Kumar Bajaj
About Rakesh Kumar Bajaj
Rakesh Kumar Bajaj has 24 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Jeps Pharma Private Limited and Medira Healthcare Limited. Formerly with 2 companies, such as Nanz Med Science Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Medira Healthcare Limited
U21002HP2025PLC011844
|
Director | 17 Jul 2025 | 2025 | Active |
Optima Pharmasol Llp
ACD-1807
|
Designated Partner | 26 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Nanz Med Science Pharma Private Limited
U24100DL2006PTC156756
|
Additional Director | 15 Mar 2019 | 2006 | Active |
Jeps Pharma Private Limited
U74899DL1989PTC038693
|
Director | 20 Aug 2001 | 1989 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Kumar Bajaj
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Kumar Bajaj
Rakesh Kumar Bajaj has 24 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Jeps Pharma Private Limited and Medira Healthcare Limited. Formerly with 2 companies, such as Nanz Med Science Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Rakesh Kumar Bajaj is associated with 2 companies as Director and Designated Partner.
Rakesh Kumar Bajaj has expertise in General Business, Healthcare.
Rakesh Kumar Bajaj has 24 years in corporate governance.